PRODUCT INFORMATION

Glycomet 850 mg is an antidiabetic agent containing metformin as the active constituent. Metformin belongs to a class of drugs known as biguanides that can be administered alone or together with sulfonylureas. It is effective when used as an adjunct to diet and exercise to improve glycaemic control in adults and children with type 2 diabetes mellitus.

The exact mechanism of action of the drug is still not understood. Still, clinical studies suggest that the antidiabetic agent plays a part in increasing the adherence of insulin to its receptors and potentiating insulin action.

The management of Type 2 diabetes requires aggressive treatment to achieve glycaemic control and cardiovascular risk factor goals. To treat diabetes mellitus, metformin, an old and widely accepted first-line agent stands out not only for its ant glycaemic properties but also for its beneficial effects beyond glycaemic control. The antidiabetic drug is also known to improve oxidative stress lipid profiles, insulin resistance, and fat redistribution. These properties contribute to a decreased risk of cardiovascular outcomes. The only thing that could rearrange the metabolic activities are the ability to control the glycaemic index.